Naproxen and cromolyn as new glycogen synthase kinase 3β inhibitors for amelioration of diabetes and obesity: an investigation by docking simulation and subsequent in vitro/in vivo biochemical evaluation.
about
Chronic over-nutrition and dysregulation of GSK3 in diseasesGlycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and ImagingNaproxen affects osteogenesis of human mesenchymal stem cells via regulation of Indian hedgehog signaling molecules.Potential Effects of Nonsteroidal Anti-Inflammatory Drugs in the Prevention and Treatment of Type 2 Diabetes Mellitus.
P2860
Naproxen and cromolyn as new glycogen synthase kinase 3β inhibitors for amelioration of diabetes and obesity: an investigation by docking simulation and subsequent in vitro/in vivo biochemical evaluation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Naproxen and cromolyn as new g ...... n vivo biochemical evaluation.
@en
Naproxen and cromolyn as new g ...... n vivo biochemical evaluation.
@nl
type
label
Naproxen and cromolyn as new g ...... n vivo biochemical evaluation.
@en
Naproxen and cromolyn as new g ...... n vivo biochemical evaluation.
@nl
prefLabel
Naproxen and cromolyn as new g ...... n vivo biochemical evaluation.
@en
Naproxen and cromolyn as new g ...... n vivo biochemical evaluation.
@nl
P2093
P2860
P356
P1476
Naproxen and cromolyn as new g ...... n vivo biochemical evaluation.
@en
P2093
Mohamed A S Al Ghussein
Mutasem O Taha
Shohda A El-Maraghy
Tarek M K Motawi
Yasser Bustanji
P2860
P304
P356
10.1002/JBT.21503
P577
2013-06-19T00:00:00Z